Mucins

Mucins are high molecular weight glycoproteins expressed by epithelial cells. Several mucin genes have ben identified or cloned (MUC1 - MUC12) and monoclonal antibodies raised against their glycoprotein products. Sequence homologies distinguish two main families. The MUC genes at 11p15 encode secreted gel-forming mucins (MUC2, MUC5AC, MUC5B, MUC6). The MUC genes at loci 7q22, 3q and 1q21 encode mainly membrane-bound mucins5.

 

Like cytokeratins, they show relative specificity for tissue types. MUC1 is identical to EMA.

MUC2 is expressed by mucinous adenocarcinomas of the colon, breast, pancreas and ovary4. CDX-2 may interact with the MUC2 promoter, activating MUC2 expression4.

 

Immunohistochemical expression

 

MUC1 (EMA)

MUC2

MUC5AC

 

breast

normal mammary gland

10/101

0/101

0/101

ductal carcinoma

13/131

0/131

0/131

GI tract

stomach

 

 

positive1

pancreas

positive1

 

 

intestinal goblet cell

 

positive1

 

rectal mucosa

0/101

10/101

3/101

anal glands

0/61

0/61

6/61

renal cell carcinoma

26/601

 

 

vulva

eccrine glands

12/121

0/121

0/121

apocrine glands

8/81

0/81

0/81

mammary-like glands

6/61

0/61

0/61

Bartholin's glands

7/71

0/71

7/71

cervix

endocervical glands

 

 

positive1

 

 

Columnar-lined oesophagus commonly expresses MUC5AC and MUC6. MUC2 is only expressed in the presence of intestinal metaplasia3.

 

MUC4 expression is acquired in dysplastic ectocervical squamous epithelium2:

normal endocervical glandular epithelium

11/11, in 50% to 100% of cells

normal ectocervical squamous epithelium

4/18, focally in parabasal cells

squamous metaplasia

7/9, in 10% to 50% of parabasal cells

CIN I

17/19, in all layers of the epithelium

CIN II

7/7, in all layers of the epithelium

CIN III

9/9, in all layers of the epithelium

   

 

MUC4 is also expressed by intermediate trophoblast:

 

Placental site nodule

1/96

 

Placental site trohoblastic tumour

8/86

Epithelioid trophoblastic tumour

4/146

Choriocarcinoma

32/326

   

Diagnostic utility

 

References

1Kuan, S. F., Montag, A. G., Hart, J., Krausz, T., Recant, W. Differential expression of mucin genes in mammary and extramammary Paget's disease. Am J Surg Pathol 2001;25:1469-1477.

2 Lopez-Ferrer, A., Alameda, F., Barranco, C., Garrido, M., de Bolos, C. MUC4 expression is increased in dysplastic cervical disorders. Human Pathology 2001;32;1197-1202.

3Warson, C., J. H. Van De Bovenkamp, et al. (2002). "Barrett's esophagus is characterized by expression of gastric-type mucins (MUC5AC, MUC6) and TFF peptides (TFF1 and TFF2), but the risk of carcinoma development may be indicated by the intestinal-type mucin, MUC2." Hum Pathol 33(6): 660-8.

4Cathro, H. P. and S. E. Mills (2004). "Immunophenotypic differences between intestinal-type and low-grade papillary sinonasal adenocarcinomas: an immunohistochemical study of 22 cases utilizing CDX2 and MUC2." Am J Surg Pathol 28(8): 1026-32.

5 Handra-Luca A, Lamas G, Bertrand JC, et al. MUC1, MUC2, MUC4, and MUC5AC expression in salivary gland mucoepidermoid carcinoma: diagnostic and prognostic implications. Am J Surg Pathol 2005; 29:881-9

6 Mao TL, Kurman RJ, Huang CC, et al. Immunohistochemistry of choriocarcinoma: an aid in differential diagnosis and in elucidating pathogenesis. Am J Surg Pathol 2007; 31:1726-32

 

This page last revised 3.1.2008.

©SMUHT/PW Bishop